-
ImmunoGen, Inc.’s
IMGN
shares jumped 5.5% after it announced CFO Susan Altschuller would not return from her time off.
-
Shares of TG Therapeutics, Inc.
TGTX
skyrocketed 22.9% on news that the FDA had approved its drug, Briumvi, for treating multiple sclerosis.
-
Tesla, Inc.’s
TSLA
shares surged 8.1% after Elon Musk reportedly reassured staff that they should not be bothered by the stock market craziness.
-
Shares of Microsoft Corporation
MSFT
advanced 2.8% on a broader tech rally.
Zacks Top 10 Stocks for 2023
In addition to the investment ideas discussed above, would you like to know about our 10 top picks for the entirety of 2023? From inception in 2012 through November, the
Zacks Top 10 Stocks
portfolio has tripled the market, gaining an impressive +884.5% versus the S&P 500’s +287.4%.
Now our Director of Research is combing through 4,000 companies covered by the Zacks Rank to handpick the best 10 tickers to buy and hold. Don’t miss your chance to get in on these stocks when they’re released on January 3.
Be First to New Top 10 Stocks >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report